ADAMTS13 and thrombotic thrombocytopenic purpura: Re-elevation of ADAMTS13 inhibitor levels (ie, inhibitor boosting) after completion of TPE may lead to a decrease in ADAMTS13 activity and subsequent recurrence of TTP [13].